Characteristic N=339 n (%)
Gender  
Female 223 (65.8)
Male 116 (34.2)
Age (years)  
≤ 40 173 (51.0)
>40 166 (49.0)
Marital status  
Married 201 (59.3)
Single 46 (13.6)
Separated/divorced 22 (6.5)
Widowed 70 (20.6)
Educational status  
None/Primary 91 (26.9)
Secondary 158 (46.6)
Tertiary 90 (26.5)
Residence  
Urban 191 (56.3)
Rural 148 (43.7)
Household income (Naira)  
<20,000 186 (54.9)
20-50,000 73 (21.5)
51-100,000 50 (14.7)
>100,000 30 (8.8)
Household size/No of dependents  
4 114 (34.3)
8-May 158 (47.6)
>8 60 (18.1)
People per room  
≤2 241 (71.1)
>2 98 (28.9)
Socio-economic class  
Upper (class I) 27 (8.0)
Middle (class II & III) 141 (41.6)
Lower (class IV & V) 171 (50.4)
Duration of HIV diagnosis (years), median (IQR) 3.4 (2.0-6.0)
HAART duration (months), median (IQR) 35.0 (20.0-50.0)
HAART adherence, n (%) 263 (77.6)
Baseline WHO clinical stage  
1-2 245 (72.3)
3-4 94 (27.7)
Baseline CD4 cell count (cells/µL)  
<200 168 (49.6)
200-499 159 (46.9)
≥500 12 (3.5)
Current CD4 cell count (cells/µL)  
<200 75 (22.1)
200-499 180 (53.1)
≥500 84 (24.8)
Baseline hemoglobin (g/dl), mean ± SD 11.2 ± 2.0
Current hemoglobin (g/dl), mean ± SD 11.6 ± 1.8
HAART= Highly Active Antiretroviral Therapy; HIV=Human Immunodeficiency Virus;
IQR= Interquartile Range; SD= Standard Deviation; WHO= World Health Organization
Table 1: Socio-demographic and clinical characteristics of the study participants.
Goto home»